Townsend Asset Management Corp Abbott Laboratories Transaction History

Townsend Asset Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$109.52 - $120.96 $248,281 - $274,216	2,267 New	2,267 $257,000
Q2 2022 Jul 25, 2022	SELL	$102.07 - $123.37 $177,193 - $214,170	-1,736 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$114.02 - $139.04 $7,297 - $8,898	-64 Reduced 3.56%	1,736 $205,000
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $195,912 - $230,813	1,800 New	1,800 $216,000
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $203,257 - $246,841	-2,218 Closed	0 $0

Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $169,832 - $217,364	2,218 New	2,218 $203,000

3,113

1.29B

8.43M

8.19M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $188B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Townsend Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Townsend Asset Management Corp with notifications on news.